跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24,652 条关于
“fibroblast growth factor 21”
全部
24,652
临床试验
12,521
药物
1,385
机构
175
资讯
10,571
去年
Efruxifermin Plus GLP-1RA Shows Promise in MASH Treatment
去年
Doer Bio Doses First Patient in Phase 2 Trial of DR10624 for Severe Hypertriglyceridemia
去年
89bio's Pegozafermin Advances Through Phase 3 Trials for MASH and SHTG
去年
Efimosfermin Alfa Shows Promise in Phase II MASH Trial with Monthly Dosing
去年
89bio's Pegozafermin Advances in Phase 3 Trials for MASH and Severe Hypertriglyceridemia
2个月前
GSK's Efimosfermin Opens Two Phase 3 Trials Targeting MASH Cirrhosis, Signaling a Shift Toward Disease-Modifying Outcomes
去年
Syros' Tamibarotene Fails Phase III Trial in MDS Patients
去年
Long-Term Obesity Accelerates Biological Aging in Young Adults, Study Finds
去年
Doer Biologics Completes Phase 2 Enrollment for Novel Tri-Specific Agonist Targeting Severe Hypertriglyceridemia
2年前
GSK Acquires Boston Pharmaceuticals' Efimosfermin for Liver Disease in $2 Billion Deal
第 1 页，共 1058 页
上一页
下一页
